Although similar studies have been performed to explore the connection between cancer, microRNAs, and cancer inhibitors, up to now there's few researches that combine FOXP3 with microRNAs or MYC, let alone the specific miR‐198, which means the underlying mechanism of the important tumor suppressor FOXP3 still needs exploring. This evidence concerns the gene MYC and neoplasm.